论文信息 - Myelodysplasia Following Treatment of Chronic Lymphocytic Leukaemia with Fludarabine.

Myelodysplasia Following Treatment of Chronic Lymphocytic Leukaemia with Fludarabine.

Recently there has been an increased awareness of a possible link between the use of purine nucleoside analogues and myelodysplasia. We report the case of a patient who developed myelodysplasia with complex cytogenetic changes after receiving fludarabine. We review the literature, discuss the possible links between myelodysplasia and nucleoside analogues and putative mechanisms for secondary neoplasia.

A. Kasprzyk | C. Reid | B. J. Hennessy | S. Ryley

[1] A. Hagemeijer,et al. Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2‐chloro‐2′‐deoxyadenosine , 1999, British journal of haematology.

[2] B. Bain,et al. Persistent bone marrow failure with dysplastic features following pentostatin therapy for hairy cell leukaemia. , 1998, Clinical and laboratory haematology.

[3] Bolam,et al. Association of myelodysplastic changes with purine analogues , 1998, British journal of haematology.

[4] L. Gordon,et al. Long term follow‐up and late complications of 2‐chlorodeoxyadenosine in previously treated, advanced, indolent non‐hodgkin's lymphoma , 1998, Cancer.

[5] D. Betticher,et al. Myelodysplastic syndrome with biclonal monosomy 7 and trisomy 8 after treatment with cladribine (2-chloro-2-deoxyadenosine) and involved field radiation therapy. , 1997, Cancer genetics and cytogenetics.

[6] A. Smith,et al. Myelodysplasia occurring after fludarabine treatment for chronic lymphocytic leukaemia. , 1997, Clinical and laboratory haematology.

[7] S. Kroft,et al. Plasmacytoid leukemia of chinook salmon , 1997 .

[8] E. Estey,et al. Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia. , 1994, Leukemia.